2021
Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC
Adams C, Jadi R, Segovia-Chumbez B, Daag J, Ylade M, Medina F, Sharp T, Munoz-Jordan J, Yoon I, Deen J, Lopez A, de Silva A, Premkumar L. Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 3073-3081. PMID: 34808091, PMCID: PMC8632176, DOI: 10.3201/eid2712.211150.Peer-Reviewed Original ResearchConceptsZIKV seroprevalenceDENV transmissionEnvelope domain IIIZika virusSerologic assaysInfectious Diseases journal - CDCType-specific antibodiesDengue virus serotypesYears of agePublic health laboratoriesRelated flavivirusesHealth laboratoriesFlaviviridae familySeroprevalenceChildren 9Virus serotypesDomain IIIVirusAntibodiesAssaysDENVFlaviviruses
2017
Dengue IgG Seropositivity and Zika Viral Load
Read J, Alvarado L, Torres-Velasquez B, Munoz-Jordan J, Beltran M, Capre S, Adams L, Torres-Torres S, Santiago G, Rivera L, Rivera-Sánchez A, Lorenzi O, Sharp T, Garcia-Gubern C, Waterman S. Dengue IgG Seropositivity and Zika Viral Load. Open Forum Infectious Diseases 2017, 4: s301-s302. PMCID: PMC5631870, DOI: 10.1093/ofid/ofx163.695.Peer-Reviewed Original ResearchPrevious DENV infectionSymptomatic ZIKV infectionDENV IgGDENV infectionZIKV infectionSecondary dengue virus infectionIgG-positive specimensProportion of patientsDengue virus infectionYears of ageIllness surveillance systemZIKV PCRIgG seropositivityRT-PCR resultsLinear regression modelingViral loadIgG assaysPrimary infectionVirus infectionInclusion criteriaStudy populationDENVHouse ELISAInfectionMann-Whitney